Luigi Biasco interviews Scott Lim and Konstantinos P. Koulogiannis, Principal Investigators of CLASP IID.
The trial demonstrated safety and effectiveness of the PASCAL system and met non-inferiority endpoints, expanding transcatheter treatment options for prohibitive surgical risk patients with significant symptomatic DMR.
More interviews and articles about the TCT Congress 2022 on PCRonline: [ Ссылка ]
